T3	Treatment 32 48	6-mercaptopurine
T4	Effect 49 86	myelotoxicity and therapeutic failure
T5	Subject 90 132	children with acute lymphoblastic leukemia
T7	Age 90 98	children
T8	Sub-Disorder 104 132	acute lymphoblastic leukemia
T9	Drug 32 48	6-mercaptopurine
